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Grey matterExtensiveworldwide efforts are underway toproduceknockoutmice for each of the ~25,000mouse genes,which
may give new insights into the underlying pathophysiology of neurological disease. Microscopic magnetic
resonance imaging (μMRI) is a key method for non-invasive morphological phenotyping, capable of producing
high-resolution 3D images of ex-vivo brains, after ﬁxation with an MR contrast agent. These agents have been
suggested to act as active-stains, enhancing structures not normally visible onMRI. In this study, we investigated
the structural correlates of the MRI agent Gd-DTPA, together with the optimal preparation and scan parameters
for contrast-enhanced gradient-echo imaging of the mouse brain. We observed that in-situ preparation was
preferential to ex-situ due to the degree of extraction damage. In-situ brains scannedwith optimised parameters,
enabled images with a high signal-to-noise-ratio (SNR ~30) and comprehensive anatomical delineation. Direct
correlation of the MR brain structures to histology, detailed ﬁne histoarchitecture in the cortex, cerebellum,
olfactory bulb and hippocampus. Neuroﬁlament staining demonstrated that regions of negative MR contrast
strongly correlated to myelinated white-matter structures, whilst structures of more positive MR contrast
corresponded to areas with high grey matter content. We were able to identify many sub-regions, particularly
within thehippocampus, such as theunmyelinatedmossyﬁbres (stratum lucidum) and their regionof synapse in
the stratum pyramidale, together with the granular layer of the dentate gyrus, an area of densely packed cell
bodies, whichwas clearly visible as a region of hyperintensity. This suggests that cellular structure inﬂuences the
site-speciﬁc distribution of the MR contrast agent, resulting in local variations in T2*, which leads to enhanced
tissue discrimination. Our ﬁndings provide insights not only into the cellular distribution and mechanism of MR
active-staining, but alsoallow for threedimensional analysis,which enables interpretationofmagnetic resonance
microscopy brain data and highlights cellular structure for investigation of disease processes in development and
disease.S, central nervous system; Gd-
d; SNR, signal-to-noise ratio;
umber of signal averages; TE,
ical Imaging, University College
ondon, WC1E 6DD, UK.
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An ever-increasing number of mice are being created through
genetic manipulation to advance the goal of translational neuroscience
to produce and identify mouse models of human conditions. In order toinvestigate and validate these mouse models, detailed studies must be
undertaken of the mouse brain. Phenotyping the brain conventionally
relies on examination of cellular and anatomical structures by histology.
While this method is ideal to visualise physiological or pathological
changes on a cellular and architectural level, tissue processing artefacts
and shrinkage affect the reliability of 3D volumetric assessments.
Effective methods for rapid, non-invasive phenotyping are thus needed
for the analysis of mouse mutants.
In recent years these efforts have been advanced by the increasing
use ofmicroscopicMRI (μMRI) to characterisebrainphenotypes of novel
mouse mutants. MRI offers a number of advantages over traditional
histological sectioning, namely its ability to produce non-invasive
datasets, which allow the accurate calculation of volumes without
975J.O. Cleary et al. / NeuroImage 56 (2011) 974–983distortion. Morphometric techniques may then be used to allow the
identiﬁcation of novel phenotypes. Work in this ﬁeld has lead to
the creation of non-invasive mouse brain atlases (Dorr et al., 2008; Ma
et al., 2005) and has generated new insights into models such as
Huntingdon's disease and age-related neurodegeneration (Lerch et al.,
2008; Sawiak et al., 2009b; Wetzel et al., 2008).
μMRI produces high resolution datasets of ex-vivo tissue with
isotropic resolutions of less than 100 μm (typically between
21.5–70 μm in most brain studies (Badea et al., 2007b; Sawiak et al.,
2009a). This can be technically challenging, with each voxel
representing a tissue volume of b1 nL, conventionally requiring long
scan times to obtain sufﬁcient signal-to-noise (SNR). The innovation
of tissue active staining, where gadolinium-chelate MR contrast
agents are used during the ﬁxation process to shorten T1 relaxation,
has enabled the acquisition of high SNR 3D datasets with greatly
reduced scan times (Johnson et al., 2002a).
The appearance of μMR images acquired in this manner is sensitive
to preparation and scan parameters including the contrast agent,
ﬁxation concentration and pulse-sequence used (Cleary et al., 2009).
It has been recently shown that the use of higher contrast agent
concentrations (N5 mM Gd-DTPA) as part of the ﬁxation of mouse
brains excised from the skull (ex-situ), in combination with a 3D
gradient-echo sequence, can produce images with high contrast,
delineating a number of brain structures seen on conventional
histology (Huang et al., 2009; Kim et al., 2009).
The combination of a high contrast agent concentration with in-situ
preparation may produce enhanced neuroanatomical contrast and
allow more detailed and sensitive morphometric atlases, with clearer
delineation of regions of phenotypic change. Resulting volume mea-
surements and morphometric analysis may also be less affected by
preparation than ex-situ brains (Badea et al., 2007a). However, there is
little data in the literature comparing ex- and in-situ brains by MRI.
Furthermore, the timecourse for optimal ﬁxation of in-situ brains with
anMR contrast agent is unknown and a direct histological correlation of
brain structures enhanced through gradient-echo imaging together
with active-staining has not been performed.
The speciﬁc aims of our study were to investigate enhanced tissue
contrast using an active-stain μMRI preparation and optimised scanning
protocol (Cleary et al., 2009) for imagingadultmousebrains. Speciﬁcally
we have assessed the effect of active-staining on perfuse- and simple
immersion-ﬁxed ex-situ brains and monitored the in-situ MR tissue
characteristics over a period of 9 weeks. Furthermore, we sought to
identify the optimal imaging parameters to enable rapid imaging of in-
situ brains in 3 h with a standard imaging coil. In particular we have
assessed contrast-enhanced brain structures via a direct comparison
with tissue histology, which may give insights into the cellular distri-
bution and mechanism of MR active-staining.
Materials and methods
Animal preparation
Wild-type Tc1mice (n=8) (O'Doherty et al., 2005)were taken from
a colony maintained by mating Tc1 females to F1 (129 S8×C57BL/6)
males. The mice were culled by an overdose of sodium pentobarbitone
administered by injection.
Ex-situ brain study
In order to investigate the preparation of excised brains we
compared the effects of perfusion-ﬁxation to simple immersion-
ﬁxation. Two of 4 mice were given an initial saline ﬂush (15–20 ml of
normal saline at a ﬂow rate of 3 ml/min introduced via a needle in the
left ventricle) and then perfusion-ﬁxed with 50 ml of 4% buffered
formol-saline (Pioneer Research Chemicals, Colchester, UK) with
8 mMGd-DTPA (Magnevist, Bayer-Schering Pharma, Newbury, UK) at
a ﬂow rate of 3 ml/min; the remaining 2micewere simply culled. All 4brains were then carefully extracted from the skull and post-ﬁxed in
4% buffered formol-saline (with 8 mM Gd-DTPA) at 4 °C.
In-situ study
For in-situ brain MRI, 4 mice were perfusion-ﬁxed as previously
described with 2 ﬁxed using formol-saline perfusate alone and 2 with
formal-saline with 8 mM Gd-DTPA. After this, mice were decapitated
and skin, muscle, lower jaw, tongue, nasal bones and zygomatic
arches removed, with the remaining intact skulls post-ﬁxed in 4%
buffered formol-saline (with 8 mM Gd-DTPA) at 4 °C.
Imaging
All imaging was performed on a Varian 9.4 T DirectDrive VNMRS
system (Varian Inc., Palo Alto CA, USA) with a 26 mm quadrature
birdcage coil (RAPID Biomedical GmbH, Würzburg, Germany).
Samples were removed from ﬁxative and excess solution carefully
blotted with a paper towel. They were then immersed in Fomblin
perﬂuoropolyether (type PFS-1, Solvay Solexis S.p.A., Bollate, Italy) in
20 ml plastic syringes and immobilised with surgical gauze. Samples
were allowed to equilibrate for at least 2 h at room temperature prior
to imaging. Air bubbles in samples were minimised by the
equilibration time and gentle agitation of the syringe.
Ex-situ study
T1, T2* and 3D gradient-echo images of the 4 ex-situ brains were
obtained after a 7 day ﬁxation. One immersion ﬁxed and 1 perfusion-
ﬁxed brain were then reimaged after 2 week ﬁxation and further T1, T2*
and 3D gradient-echo images obtained. Parameters: single sagittal slice
0.5 mm thick), matrix=128×64, FOV=18×9mm, NSA=4, TR was at
least 5×T1. T1: inversion-recovery spin echo, 17 TIs (range 6–400 ms),
TE=10ms; T2*: gradient echo, FA=90°, 11 TEs (2.9–14 ms). 3D RF-
spoiled gradient-echo imaging: FOV=18×18×9mm, TR=20 ms,
FA=60°, NSA=6, matrix=256×256×128, TE=9 or matrix=450×
450×225, TE=6 ms.
In-situ study
Four wild-type Tc1 skulls were ﬁxed and imaged over a 5 week
period. T1 and T2* mapswere obtained at each time point. Parameters:
single sagittal slice (0.5 mm thick), matrix=128×85 (reconstructed
on the console to 128×128), FOV=19.5×13mm, NSA=4. TR was at
least 5×T1. T1: inversion-recovery spin echo, 13 TIs (range appropri-
ate for estimated T1), TE=10 ms; T2*: gradient echo, FA=90°, 8 TEs
(range appropriate for estimated T2*). 40 μm isotropic, structural 3D
gradient-echo images at unoptimised parameters were also obtained
(FOV=20.48×13.04×13.04 mm, matrix size=512×326×326,
TE/TR/FA=6 ms/20 ms/60°, NSA=2 or 6). Measured tissue param-
eter values were input into a Matlab program (The Mathworks Inc.,
Natick MA, USA) employing the theoretical equation for spoiled
gradient echo signal Eq. (1) to determine the approximate optimal
scan parameters for maximal cortex–corpus callosum contrast in a 3 h
scan-time, as described previously (Cleary et al., 2009).
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The effect of echo time on brain contrast was also investigated
experimentally by repeated imaging of one brain at 5 weeks ﬁxation
with 5 different echo-times (3.8–7 ms).
Delineation of anatomy on MRI and histological correlation
Four additional perfusion-ﬁxed in-situ brains were then imaged
using our ﬁnal protocol after 9 weeks ﬁxation (males, ages 18–
21 weeks) in 4% buffered formol-saline (with 8 mM Gd-DTPA), using
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meters: FOV=20.48×13.04×13.04mm,matrix size=512×326×326,
TE/TR/FA/NSA=4ms/17 ms/52°/6.
One brain was carefully extracted from the skull, dehydrated using
graded alcohols and xylene, embedded in parafﬁn, cut into 3-μmsagittal
sections and processed for haematoxylin–eosin (H&E) and Luxol Nissl
staining. Antibodies or antisera against the following antigens were
used: GFAP (DAKO Z0334), MAP-2 (Chemicon MAB3418), Neuro-
ﬁlament 200 (Sigma N5389); and myelin basic protein (SMI94). All
immunostaining was carried out using the automated Ventana
Benchmark or Discovery (Ventana Medical Systems) automated
staining apparatus following the manufacturer's guidelines, using
biotinylated secondary antibodies and a horseradish peroxidase-con-
jugated streptavidin complex and diaminobenzidine as a chromogen.
Slides were photographed with a SIS Megaview 3.2 megapixel digital
camera mounted on a ZEISS Axioskop.
Image processing
T1 and T2* maps were created by a pixel-by-pixel, least-squares ﬁt of
the resulting data using in-house C-programs. The inverse of thesewere
also calculated, using ImageJ (National Institutes of Health, Bethesda
MD, USA), producing corresponding maps of R1 and R2*. Statistical
analysis of map values was performed in Prism v5.00 (GraphPad
Software, San Diego CA, USA). 3D volume images were reconstructed
and converted to Analyze format using custom Matlab code and
reviewed in ImageJ. SNR and CNR were measured in a number of brain
regions by taking the ratio of average and signal differences in whole-
structure volumes and the standard deviation in a region of background
noise Eq. (2):
SNR =
Signal
Noise SD
CNR =
Signal1−Signal2
Noise SD
: ð2Þ
Visualisation of brain structures was performed in Amira software
(v5.2.2, Visage Imaging Inc., Andover MA, USA).
Results
Ex-situ study: comparison of immersion and perfusion-ﬁxed brains at
two ﬁxation durations.
After 7 days immersion in contrast-ﬁxative, there was no signif-
icant difference in T1 and T2* values between the immersion and
perfusion-ﬁxed brains (pN0.40 in all comparisons) (Table 1). T1 and
T2* measurements were repeated at 2 weeks (Fig. 1). We observed a
similar change in whole-brain T1 (perfusion: 33.2 to 31.4 and im-
mersion: 35.1 to 31.7) and T2* (perfusion: 3.7 to 3.5 and immersion:
3.5 to 3.2) between 7 days and 2 weeks (Fig. 1). We noted that the
immersion-ﬁxed brains had sustained some additional cortical
damage during the extraction process when compared to the
perfusion-ﬁxed brain (Fig. 2). Furthermore, cortical vessels, although
present in both immersion and ﬁxed brains, were more apparent
in the perfusion-ﬁxed brains, otherwise the brains from the two
methods appeared similar. This comparison indicates that the use of a
simpler immersion-ﬁxation method, where the brain is removedTable 1
Table showing T1 and T2* values in brains after 7 days immersion only or with initial perfus
Region of interest Perfusion Fixation (n=2)
Cortex Cerebellum Who
T1 (ms) 32.2±0.4 31.8±0 33.2
T2* (ms) 4.4±0.6 5.1±0.8 3.7directly from the skull without perfusion-ﬁxation, would facilitate
magnetic resonance microscopy techniques, if damage from extrac-
tion is not a confounder.
In-situ study
Given that varying degrees of cerebellar and cortical damage was
apparent in all brains imaged, we explored the feasibility of contrast-
enhanced imaging with the brain in-situ. Initially we investigated
whether the addition of 8 mM Gd-DTPA in the initial perfusate would
improve the rate of T1 reduction over perfuse ﬁxation and immersion
ﬁxation alone. After measurement of T1 and T2* values in each group
after 1 week ﬁxation, it was apparent that there was no signiﬁcant
difference (pN0.65) in T1 data: therefore all brains were pooled in
subsequent analysis. We measured MR parameters over 1, 2, 3, and
5 weeks. Table 2 demonstrates that T2* values were found to reach a
minimum at 3 weeks immersion (mean thalamus–midbrain=2.9 ms,
cortex=3.8 ms). In contrast, T1 values continued to reduce after
3 weeks, approaching uniformity across the brain by the 5 week
timepoint (mean thalamus–midbrain region=48±3 ms, cortex= 43
±2 ms, Table 2). Fig. 3 illustrates the corresponding regional R1 changes
occurring over 5 weeks. We observed that a greater immersion time
lead to a lower T1 (e.g. whole-brain T1: 1 week 109±53 vs. 5 weeks 44
±2 ms, pb0.05, Table 2) and also reduced the magnitude of T1
difference between cortical and midbrain–thalamus structures deep in
the centre of the brain (e.g. mean difference at 1 week=15 ms vs.
5 weeks=5 ms, Table 2). An increase in the conspicuity ofwhitematter
structures (such as ﬁbres of the internal capsule) was observed on 3D
images with increasing immersion time (Fig. 3).
Scan parameter optimisation
From calculations using mean T1 across the whole-brain at
5 weeks immersion, we determined that parameters of TR=17 ms,
NSA=6, at the whole-brain Ernst angle (47°) would produce the
highest SNR (assuming constant noise), in a 3 h scan time. From the T2*
data at 1 week we estimated the ratio of M0 in the corpus callosum
relative to cortex in the 4 brains to be 0.96±0.01. Using these
estimates and T2* values from our maps at 5 weeks, we calculated that
a TE of approximately ~3.4 ms would give optimal cortex/corpus
callosum contrast. To ascertain the optimal TE at 5 weeks experimen-
tally, we performed repeated high-resolution scans of a single brain
from our dataset with the calculated TR, NSA and ﬂip angle above.
Fig. 4 shows the effect of varying TE from 3.8 ms (the minimum
permitted by the system at 100 kHz bandwidth) to 7 ms. Although
SNR in all structures was highest at TE=3.8 ms (whole-brain
SNR=31.5), cortex–corpus callosum CNR appeared to be maximal
at TE=4 ms (CNR=7.5, whole-brain SNR=30.3). Interestingly
white-grey matter CNR in the cerebellum peaked slightly later at a
TE=5 ms (CNR=22.4). As indicated in Fig. 5, it was noted that
increasing echo time appeared to enhance the delineation of more
subtle structures, such as cortical layers and the layer of Purkinje cells
in the cerebellum, indicating a T2* dependency to this contrast. Opting
for a balance of high SNR and high grey-white matter CNR, we chose
ﬁnal parameters of TE=4 ms, FA=47° (the Ernst Angle), TR=17 ms
and NSA=6 averages for future studies.ion-ﬁxation (mean values±SD).
Immersion ﬁxation (n=2)
le-brain Cortex Cerebellum Whole-brain
±0.2 33.1±1.3 28.2±6.2 34.2±1.3
±b0.1 4.4±0.2 5.2±0.2 3.8±0.3
Fig. 1. T1 and T2* maps showing similar sagittal slices and mean, whole-brain T1 and T2* values through representative immersion and perfusion-ﬁxed brains after 7 days and 2 weeks.
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After identifying the need for a long immersion duration to enable
full penetration of contrast agent, we applied the above optimised
parameters (FA=52°, appropriate for these T1s) to a further 4 in-situ
brains after 9 weeks immersion, acquiring T1 and T2* maps and high-
resolution 3D volumes. Compared to 5 week data, while R2* values
remained similar in both cortical and thalamus–midbrain regions to
our previous brains (Fig. 6B), R1 showed a more marked increase
(Fig. 6A), with the corresponding whole-brain T1 measured as 35±
2 ms compared to 44±2 ms of previous brains at 5 weeks. As seen in
a corresponding R1 map of a sagittal slice through an example brainFig. 2. Representative slices through 3D volumes of brains im(bottom right, Fig. 6), values have a narrow distribution across the
brain (SD of T1 values over whole-brain ROI=3.8±0.1 ms, n=4)
indicating that 9 weeks immersion may be more suitable. Whole-
brain SNR was comparable to previous 5 week data and measured to
be ~30.
Structural correlates of active-staining in the brain
The resulting gradient echo images acquired at the selected
parameters (TE/TR/FA/NSA=4ms/17 ms/52° Ernst angle/6 averages),
after 9 weeks in contrast-ﬁxative, demonstrated excellent contrast,
enabling the delineation of a number of structures in the cortex,aged after 2 weeks ﬁxation (40 μm isotropic resolution).
Table 2
Table showing T1 and T2* values within cortical and central thalamus–midbrain regions
of interest over 5 weeks ﬁxation.
(n=4) T1 (ms) T2* (ms)
Region of interest Thalamus–
midbrain
Cortex Thalamus–
midbrain
Cortex
Immersion duration
1 week 113±32 99±23 6.1±1.5 6.3±1.1
2 weeks 67±5 55±4 3.4±0.2 4.3±0.3
3 weeks 61±7 49±3 2.9±0.2 3.6±0.3
5 weeks 48±2 42±2 3.2±0.2 4.0±0.1
978 J.O. Cleary et al. / NeuroImage 56 (2011) 974–983hippocampus, olfactory bulb and cerebellum (Fig. 7, sagittal image). In
the hippocampus, individual layers were clearly visible such as a bright
granular cell layer of the dentate gyrus, as well as bright region of
the stratum lucidum and dark layer in the region of CA3 (Fig. 7, coronal
viewA, blue panel). Individual nucleiwere also visible, includingmedial
and lateral habenular nuclei and a number of thalamic nuclei (Fig. 7,
coronal view A, green panel). White-matter tracts were easily visu-
alised, appearingwith strongnegative contrast on gradient-echo images
(Fig. 7, coronal view B).
Sagittal MR images were compared to histology where a good
correlation was observed between a number of white matter struc-
tures deﬁned on a neuroﬁlament stained section and equivalent dark
areas on a similar MR image (Fig. 8A). Structures such as the anterior
commissure, superior colliculus commissure and fasciculus retro-
ﬂexus were easily visualised.
In the cerebellum, (Fig. 8B) structures on MR correlated well to
those seen on histology, such as the bright outer molecular layer,
consisting of mostly Purkinje cell dendrites (seen on calbindin section,
Fig. 8B), a bright granular cell layer and dark Purkinje cell layer
(evenly-spaced, large Purkinje cells visible in all sections, Fig. 8B) and
axonal ﬁbre tracts (Fig. 8B, neuroﬁlament section). While MR signal
intensity was high in both molecular and granular layers, the granular
layer appeared to be slightly hypointense.
In the olfactory bulb (Fig. 8C) the main features of mitral,
glomerular and external plexiform layers were easily identiﬁed in
MR images, with these regions correlatingwell to all stains. Sublayers in
the granular cell layer, seen on H&E and calbindin sections (Fig. 8C),
were not readily apparent on MR with images best correlating to the
more uniform appearance of the granular cell layer observed in the
neuroﬁlament section.Fig. 3. Comparison of representative R1 maps and similar volume slices from the same in-
required for values in the centre of the brain to equilibrate withmore cortical regions. Althou
weeks (bottom), there is a noticeable improvement in the quality of structural delineation, p
capsule, red arrows; mammilothalamic tract, yellow arrows). (Images identically scaled).As hippocampal anatomy was especially well deﬁned on MRI, we
sought to identify the source of the regional MR contrast by histological
comparison. In addition to standard histological stains, we also
compared our data to a standard Timm stained section—an established
method of visualising the presence of intracellular Zn2+ that char-
acterises hippocampal mossy ﬁbres (Haug et al., 1971). Fig. 9A shows a
comparisonof hippocampal structureswith a similar axial Timmsection
from a C57BL/6mouse (Crusio et al., 1986).We observed a conspicuous
area of hypointensity in the stratum pyramidale region of CA3 (orange
arrows, Figs. 9A and B), which correlated with unmyelinated mossy
ﬁbres synapsing with pyramidal cells (Figs. 9A(iv) and B, Timm and
calbindin sections respectively). Previously, we had observed that
hypointensity was associated with myelinated white matter structures
(Fig. 8A), which is not the case in the stratum pyramidale. An area of
myelinated ﬁbres in the dentate gyrus molecular layer (Fig. 9B, blue
arrows) did not result in a hypointensity onMRI. Closely associated and
lateral to the stratum pyramidale (concave aspect; red arrows) are the
suprapyramidalmossy ﬁbres (running in the stratum lucidum) a region
of unmyelinated axonal ﬁbres (Figs. 9A and B, Timm and calbindin
sections) that appeared as an area of hyperintensity within CA3. The
granular layer of the dentate gyrus (green arrows, Fig. 9A) was clearly
visible as a region of hyperintensity that correlated to a dense area of
closely packed cell bodies (Fig. 9B, H&E and calbindin sections).
Discussion
After an initial investigation of ex-situ brains which showed a high
degree of extraction damage.We have demonstrated that in-situ brains
prepared ina solutionof 8mMGd-DTPAand imagedwithgradient-echo
sequence produced high-resolution (40 μmisotropic), high SNR images,
with a 3-hour scan time.We have also shown that structures delineated
on MR directly correlate to those deﬁned on histology, such as major
white matter tracts and layers of the olfactory bulb and hippocampus.
This comparison has then enabled us to assess the effects of tissue
microstructure on MR contrast of actively-stained tissue.
Ex-situ brain imaging
Ex-situ brain imaging with a gradient-echo sequence has been
reported previously (Huang et al., 2009; Kim et al., 2009) and our ex-situ
brains show T1 and T2* values are in line with those studies (T1≈30 ms,
T2≈7 ms, 10 mMGd-DTPA, after 4 days immersion in contrast-ﬁxative
(Kim et al., 2009)) displaying similar image contrast. Additionally wesitu brain over 5 weeks ﬁxation. As seen in R1 maps (top) a greater amount of time is
gh amodest SNR enhancement may be seen in 3D gradient-echo images after successive
articularly in the hippocampus (blue-arrows) and white matter structures (e.g. internal
Fig. 4. Representative sagittal slice (A) and measured SNR (B) and CNR (C) from 3D volume data of a brain imaged after 5 weeks ﬁxation at ﬁve different echo times.
979J.O. Cleary et al. / NeuroImage 56 (2011) 974–983have shown that these values remain relatively unchanged even after
extending the immersion time to two weeks (e.g. mean T1 perfusion-
ﬁxed went from 33 to 31 ms) to leave more time for Gd-DTPA
penetration. We have demonstrated that brains need not be perfu-
sion-ﬁxed and that simple immersion-ﬁxation produced equivalent
image quality, thus enabling magnetic resonance histology in labora-
tories where perfusion-ﬁxation is not readily available. Imaging of
extracted, ex-situ brain tissue does have some advantages, in that
smaller RF coils can be used, improving SNR and a smaller ﬁeld of view
may improve imaging-time (Kim et al., 2009). However the tissue
damage observed in our ex-situ brains may compromise their use for
automated and quantitative morphometric analyses where accurate
anatomical volumes and morphology are essential for sensitivity.Fig. 5. Enlarged sections of cerebellar lobe and cortex showing their appearance at TE=3.8
appear to become more deﬁned at a longer TE, as does the visibility of cortical layers. (ImaIn-situ brain optimisation
Given the effect of damage in ex-situ imaging we have focussed on
in-situ brain preparation and MR methods optimisation to produce
detailed images of the mouse brain. We demonstrated that full
penetration of Gd-DTPA into brain tissue, as assessed by R1 values in
the cortex and basal ganglia, had equilibrated across the brain by
9 weeks. Indicating that a much greater immersion time is required
than in the ex-situ brain in order to produce the maximal increase in
SNR, and thus image quality, across the brain.
Currently there is no standard protocol for in-situ brain prepara-
tion and scan parameters, with a number of approaches in current use.
A T2-weighted 3D fast spin-echo sequence (FSE) with brains ﬁxed inand 7 ms. Red arrows appear to correlate to the Purkinje layer of the cerebellum and
ges identically scaled).
Fig. 6. Graph showing the timecourse of R1 (A) and R2* change (B) with immersion time
in ﬁxative+Gd-DTPA solution, incorporating values from the previous 5 week study
and 9 week brains indicating a minima has been reached. Representative R1 maps from
5 and 9 week brains shown for illustration (C).
Fig. 7. Sagittal and corresponding coronal views through a brain ﬁxed for 9 weeks and
imaged at optimised parameters. Sagittal view (top) shows the principal anatomical
structures seen. Coronal view (A) shows hippocampal anatomy visible (blue panel) and
visible nuclei (green panel). Coronal view (B) shows visible white-matter tracts.
980 J.O. Cleary et al. / NeuroImage 56 (2011) 974–9832 mM gadoteridol (a non-ionic macrocyclic Gd-chelate) for at least
7 days (Tyszka et al., 2006) is able to produce T2-weighted images of
multiple in-situ brains with a 32 μm resolution in a 11.3 h scan, and
has been successfully used for morphometric phenotyping (Ellegood
et al., 2010) and atlasing (Dorr et al., 2008) studies. While this can
offer good T2-weighted images with an improved imaging time, the
use of an FSE sequence can lead to image blurring and a loss of
structural deﬁnition (Mulkern et al., 1990).
Partial-Fourier spin-echo has also been successfully used for in-situ
phenotyping studies giving T1-weighted images with 21.5 μm resolu-
tion in a ~2 h scan time(Badeaet al., 2007b). Sharief and Johnson (2006)
developed an innovative multi-echo T2 sequence where reconstructed
images combine data from a number of echo times. This has the effect of
improving contrast, especially in T2-dependent structures such as in the
cortex and brain nuclei. In both these imaging protocols, brains are
initially perfusion-ﬁxed with a high concentration (50 mM—assuming
a standard 0.5 M clinical solution) of gadoteridol and ﬁxed overnight
10% formalin prior to imaging.Our results indicate that, in the in-situ brain, such short immersion
periods may not be sufﬁcient to give maximal T1 reduction (and thus
SNR gain) over the whole brain. If we assume that a T1 of ~31 ms (2-
week ex-situ data) is a likely minima for values after Gd immersion, we
nearly achieve this level after 9 weeks (whole-brain T1~35 ms). The
need for such an increase in immersion time compared to ex-situ brains
for Gd penetration ismost likely due to the presence of intactmeningeal
layers and limited entry points for ﬁxative into the skull (e.g. through
the foramenmagnumand orbits) resulting in a greatly reduced exposed
brain tissue surface-area.
Although a virtue of gradient-echo imaging is a short TR and thus
reduced acquisition time, this makes it sensitive to T1 differences. The
heterogeneity seen in R1 maps, corresponding to higher T1 values in
more central structures compared to cortical and cerebellar regions,
will thus limit T1 recovery, causing signal reduction in these portions
of the brain. As the majority of these regions, such as basal ganglia
and midbrain contain white-matter ﬁbres, there is likely to be an
intrinsically lower signal due to the lower T2 of myelinated structures
(Counsell et al., 2003). Thus it is important to ensure there is adequate
agent penetration to ensure full T1 recovery in these regions. Although
Fig. 8. (A) Representative sagittal sections through MRI and a similar neuroﬁlament histology section in the same brain, showing visible white-matter anatomy. (B) Detail through
the cerebellum showing the correspondence of structures between histology and MRI such as the granular, molecular and Purkinje layers and axonal ﬁbre tracts. (C) Detail through
the olfactory bulb showing layers identiﬁed on similar histology sections from the same brain.
981J.O. Cleary et al. / NeuroImage 56 (2011) 974–983TR could be increased to compensate, we have previously shown
that increased signal averaging is generally preferable to small TR
increases to boost SNR (Cleary et al., 2009) and is thus not ideal whenFig. 9. (A) Hippocampal view (ii) from an axial MRI slice (i) comparedwith a representative s
showing regions of high ionic zinc concentration, a feature of hippocampal mossy ﬁbres. Red
and green with the granular cell layer of the dentate gyrus (Timm section adapted from (Crus
compared with H&E, calbindin and myelin basic protein (MBP) stained sections. Dark regio
mossy ﬁbres and pyramidal cells. Corpus callosum (white arrows) indicated for compariso
molecular layer of the dentate gyrus.imaging with a ﬁxed scan time. The beneﬁts of allowing a greater
degree of T1 reduction are readily seen in our gradient-echo images
taken over 5 weeks (Fig. 5), in which structures of the hippocampusection from a C57BL/6mouse hippocampus stainedwith Timm silver sulphide stain (iv),
arrows indicate correspondence with mossy-ﬁbre bundles, orange with pyramidal cells
io et al., 1986). (B) Sagittal view of hippocampal anatomy from a brain ﬁxed for 9 weeks
ns on MR (orange arrows) appear to correlate with heterogeneous regions containing
n. Blue arrows in the MBP section indicate a diffuse region of myelinated ﬁbres in the
982 J.O. Cleary et al. / NeuroImage 56 (2011) 974–983and white matter tracts are more conspicuous by the last 5 week
timepoint.
Although active-staining primarily acts to reduce tissue T1 due to
administration of contrast agent (Johnson et al., 2002b; Petiet et al.,
2007) there is also a corresponding reduction in T2 (Cleary et al., 2010;
Petiet et al., 2007). This may also be exploited to produce image
contrast using much shorter TEs than in normal tissue.
In our method, the use of a relatively high contrast agent con-
centration, leads to a large mean reduction and compression of the
whole range of normal tissue T2 values. For example, as T2* is now
~3.8 ms asmeasured in the cortex (in-vivoT2≈45msat 9.4 T (Uematsu
et al., 2007)), our chosen echo-time of 4 ms results in T2*-weighting in
that region, allowing cortical layers to be visualised. Similarly, increased
T2*-weighting, improves visualisation of the Purkinje layer of the
cerebellum. Thus an 8 mM Gd-DTPA concentration with a gradient-
echo sequence with a relatively short TE and TR combines the potential
of a short scan time anda highnumber of signal averages and anoptimal
T2* weighting to reveal tissue contrast.
The contrast observed in our gradient echo images may be
explained by a combination of intrinsic tissue MR relaxation and
effect of contrast agent concentration. For example, myelinated white
matter is known to have a lower T2 than grey matter, due to higher
boundwater content (Counsell et al., 2003), giving a characteristically
darker signal on MR images in-vivo, which we also observed in our
data. This is probably best explained by contrast agent reducing T2
values but still preserving T2 differences between tissues, which can
be exploited by the correct MR parameters. Yet it has also been
suggested that distribution of the agent itself may be enhancing
contrast, particularly in non-myelinated structures (Huang et al.,
2009). Although this is unlikely to account for our observed white
matter contrast: using R1 maps as an indication of contrast agent
concentration, the lack of regional contrast in maps at 9 weeks does
not suggest a selective regional distribution of contrast agent, where
higher concentration of contrast agent would be expected to result in
area of increased R1.
Interestingly we also observed negative contrast in classically
unmyelinated regions of the hippocampus that did not appear to depend
on thepresenceof even small tracesofmyelin (as seen inourMBP-stained
section, Fig. 9B, blue arrows). Previous work in the ex-situ mouse brain
has suggested that ~23% of brain volume is inaccessible to the Gd-DTPA
indicating that the agent is not distributed uniformly at a cellular
level (Huang et al., 2009). Our study reinforces this view, as the dark
appearance of these unmyelinated regions are likely to be due to
increased local Gd-DTPA distribution and MR susceptibility at a local
level. Thus the choice of a gradient echo sequence is ideally suited to
detection of such regions, especially those with subtle T2* differences.
Both intrinsic contrast and susceptibility could explain the subtly
different appearance of molecular and granular layers of the cere-
bellum on MR. Although the granular layer contains a great number
of densely packed cells, as seen on the neuroﬁlament stain, there are
still a large number of axonal ﬁbres passing through this region. This
could result in the observed hypointensity either through intrinsic
relaxation mechanisms where the presence of such myelinated tracts,
with a lower T2*, leads to a partial volume effect with a slight loss in
signal, or the regional cytoarchitecture, comprising a mixture of cell
bodies and axons, could affect local Gd-DTPA distribution, causing a
susceptibility effect.
Similarly we observed an enhancement of the layer of Purkinje
cells with increasing echo time. This layer also contains a mixture of
large Purkinje cells surrounded by basket cell axons. However we
have observed a large T2* dependence on contrast in this region,
indicating that susceptibility effects through structural heterogeneity
play a greater role, probably due to distribution of contrast agent.
In the olfactory bulb, we observed contrast that delineated the
mitral and glomerular but not granular layers. In previous in-vivo
high-resolution T2-weighted images (Boretius et al., 2009) all of theseregions were observed including granular layers. It is conceivable that
the more complex cytoarchitecture of both glomerular and mitral
layers may explain this observation. Glomeruli are relatively large
structures that consist of a number of nerve synapses, surrounded by
glial cells (Kosaka et al., 1998); also mitral cells have axonal ﬁbres that
contribute to the olfactory tract (Shepherd et al., 2007). In contrast,
granule cells possess only dendritic processes and are without axons
(Price and Powell, 1970). This more complex structure may lead to
greater susceptibility effects in the presence of the contrast agent in
these regions.
Comparisons with previous diffusion-weighted (Shepherd et al.,
2006) and in-vivo work (Boretius et al., 2009) may offer some expla-
nation for the enhanced contrast seen in the hippocampus. The area
of the stratum lucidum has been seen as hyperintense on diffusion
images in the rat (Shepherd et al., 2006) indicating a region of restricted
diffusion that may affect the access of Gd-DTPA to the region and
thus maintain a longer T2* than surrounding tissue. Similarly, the dense
packing of granular cells in the dentate gyrus may prevent inﬁltration
of contrast into the region and also maintain a long T2* resulting in
its bright appearance.
Previous work (Benveniste et al., 2000) has shown contrast en-
hancement in the hippocampus on subsequent ex-vivo images
monitored over a period of 2 to 50 h after initial in-vivo perfusion-
ﬁxation with Gd-DTPA. Images acquired at 2 h post ﬁxation showed
a general increase in signal over the whole hippocampus, but the
granular layer of the dentate gyrus appeared particularly hyperin-
tense. The stratum pyramidale was visible as a dark band. Over
subsequent timepoints, while signal enhancement over the whole
hippocampus appeared to be maintained, the conspicuity of both
granular layer and stratum pyramidale was greatly reduced. This
evolution of contrast was attributed to the vascular nature of this
region, with intravascular retention and extravasation of contrast
agent leading to the appearance of reduced and increased signal
respectively. The initial enhancement seen in the granular layer may
indicate that the hippocampus is compartmentalised, possessing
regions accessible to the contrast agent to a greater or lesser degree.
High-resolution in-vivo imaging, without contrast, has also demon-
strated delineation of hippocampal structures in T2-weighted images,
including the stratumpyramidale, and granular and polymorphic layers
of the dentate gyrus (Boretius et al., 2009). In images with strong
weighting (TE=82ms), contrast in these regions was markedly dif-
ferent to that of ours as both dentate gyrus and stratum pyramidale
appeared hypointense, with the stratum pyramidale visible as a con-
tinuous line from CA3 to CA1. Also the granular layer of the dentate
gyrus was not easily distinguished from the polymorphic layer. These
ﬁndings suggest that in certain structures local accumulation of the
contrast agent can contribute to MR appearance more than intrinsic
tissue T2* contrast. This suggests the exciting possibility that targeting
such regions could provide the basis for the investigation of novel MR
microscopy stains.
While the presence of contrast agent is likely to contribute most to
changes in tissue parameters, an additional consideration is tissue
ﬁxation. Aldehyde ﬁxatives cause the cross-linking of proteins
(Fraenkel-Conrat and Olcott, 1948), reducing water mobility, and
resulting in a reduction of tissue MR relaxation times (Dawe et al.,
2009). A study in the rat cortical slice model (Shepherd et al., 2009)
found T1 reduced 21% after N10 day ﬁxation, although an 81% T2
reduction could be reversed after washing out the ﬁxative by
immersion in PBS. Timecourse studies in ﬁxed human brain have
also shown progressive decreases in T1 and T2, with the T1 change
occurring fastest over the initial 1–2 weeks and a slower decline after
5 weeks (Tovi and Ericsson, 1992). Grey and white matter T1
(Pfefferbaum et al., 2004) and T2 values (Blamire et al., 1999) also
tend to converge with a longer ﬁxation time. There are, however, few
studies in the literature assessing the effect of ﬁxation on the use of Gd-
chelates. Work in Xenopus oocytes (Purea and Webb, 2006) indicates
983J.O. Cleary et al. / NeuroImage 56 (2011) 974–983that ﬁxation may alter cell membrane structure, enabling the entry of
contrast into the cytoplasm. However, further experiments are
needed to examine the role of ﬁxation on contrast in active-stained
μMRI of the mouse brain.
The time needed for the penetration of agent in our methodology
may be a disadvantage, as histological techniques, especially in light
of developments in automatic sectioning systems, can provide more
detailed information in a similar amount of time. However, MRI does
offer the beneﬁts of non-destructive 3D image acquisition.
Conclusion
We have shown that active-stained μMRI can provide detailed
anatomical images of the in-situ mouse brain with high resolution and
signal-to-noise. Additionally, we have used a variety of stains to identify
and compare the MRI appearance of brain structures to those deﬁned
by histology. Combining this data, we have highlighted possible mech-
anisms for the enhanced contrast in these regions, surmising that contrast
depends on both preserved, intrinsic T2* differences as well as regions
delineatedbydistributionof active-staindue to tissuemicrostructure. This
methodology could enable greater sensitivity for the phenotypic
characterisation in mutant mouse models and enhance regions of the
mouse brain that may be targeted in future transgenic studies.
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